Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114736102B details ionic liquid bromination for high purity. Reduces waste and energy for reliable pharmaceutical intermediate supply chains.
Patent CN108059621A details anhydrous butanone purification for 5-Methylpyrazine-2-Carboxylic Acid ensuring high purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN1894265A reveals a breakthrough ternary solvent method for phosphonium salts, offering superior yields for vitamin A intermediates and reducing manufacturing costs.
Novel Ru-catalyzed asymmetric hydrogenation process for TAFIa inhibitor intermediates. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN105753844A reveals convergent synthesis for Daclatasvir intermediates improving yield and atom economy. Discover supply chain advantages and cost reduction strategies.
Patent CN113214045A reveals a novel Grignard-based synthesis for 3,5-bis(trifluoromethyl)benzyl alcohol, offering >99.5% purity and significant cost reduction in API manufacturing.
Patent CN104220406A reveals novel nickel catalysis for hydroxyphenylcyclohexanol. Delivers high purity, reduced costs, and scalable supply chain solutions for global pharmaceutical manufacturers.
Novel patent CN116478155A enables high-purity Grapiprant production with significant cost reduction and supply chain reliability for veterinary pharmaceutical manufacturers.
Patent CN114736206B reveals metal-free aqueous synthesis for quinazolinones. Achieve cost reduction and supply chain reliability with green radical cyclization technology.
Patent CN112661719B details a calcium nitrite-based route for aminothiazolyloxime, reducing wastewater and enhancing supply chain reliability for cephalosporin manufacturers.
Patent CN103524439B details a novel anastrozole synthesis improving purity and yield. Offers supply chain reliability and cost reduction for pharmaceutical manufacturing partners.
Novel green synthesis route for fluoroquinolone intermediates offering high purity and scalable production capabilities for global pharma supply chains.
Patent CN109136298B reveals a dual-enzyme membrane separation process for D-amino acids, offering >99.9% e.e. and scalable green manufacturing solutions.
Novel patent CN118724858B reveals high-yield synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing for global buyers.
Patent CN1289452C reveals an improved dehydrohalogenation process for 2-cyclopenten-1-one, offering efficient solvent recovery and simplified purification for cost-effective manufacturing.
Novel base-first hydrolysis route for Atorvastatin Calcium ensures >90% yield and high purity, offering significant cost reduction in API manufacturing.
Patent CN104177336A details efficient asymmetric oxidation for Dexlansoprazole. Achieve high optical purity and cost reduction in pharma manufacturing.
Patent CN108329194B reveals a novel binaphthol aluminum catalyst for citronellal cyclization, offering superior enantioselectivity and simplified industrial recovery.
Patent CN106478684B reveals novel copper complex synthesis. Delivers high-purity pharmaceutical intermediates with significant supply chain and cost advantages for global buyers.
Patent CN104557583A reveals green quinidine catalysis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability.